Panbela Therapeutics, Inc.

MUN:X70 Stock Report

Market Cap: €1.6m

Panbela Therapeutics Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jennifer Simpson

Chief executive officer

US$571.9k

Total compensation

CEO salary percentage92.1%
CEO tenure4yrs
CEO ownership0.0001%
Management average tenureno data
Board average tenure4.6yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Jennifer Simpson's remuneration changed compared to Panbela Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$36m

Dec 31 2023US$572kUS$527k

-US$34m

Sep 30 2023n/an/a

-US$24m

Jun 30 2023n/an/a

-US$20m

Mar 31 2023n/an/a

-US$36m

Dec 31 2022US$694kUS$506k

-US$35m

Sep 30 2022n/an/a

-US$34m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$1mUS$477k

-US$10m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$2mUS$146k

-US$5m

Compensation vs Market: Jennifer's total compensation ($USD571.92K) is about average for companies of similar size in the German market ($USD533.87K).

Compensation vs Earnings: Jennifer's compensation has been consistent with company performance over the past year.


CEO

Jennifer Simpson (56 yo)

4yrs

Tenure

US$571,921

Compensation

Dr. Jennifer K. Simpson, Ph.D. M.S.N. C.R.N.P. has been the Chief Executive Officer, President and Director of Panbela Therapeutics, Inc. (formerly known as Sun BioPharma, Inc.) since July 15, 2020. She se...


Board Members

NamePositionTenureCompensationOwnership
Jennifer Simpson
CEO, President & Director4yrsUS$571.92k0.00014%
$ 2.3
Jeffrey Mathiesen
Vice Chair & Lead Independent Director8.8yrsUS$85.14k0%
$ 0
Michael Cullen
Chairman8.8yrsUS$76.14k0.00045%
$ 7.3
Jeffrey Jacob
Director2.1yrsUS$43.63k0.000020%
$ 0.3
Daniel Donovan
Independent Director2.1yrsUS$56.13k0.00023%
$ 3.7
Arthur Fratamico
Independent Director4.6yrsUS$52.63k0%
$ 0
Donald Schemel
Independent Director8.8yrsUS$61.13k0.00045%
$ 7.3
Tanios Bekaii-Saab
Scientific Advisorno datano datano data
Andrew Ko
Scientific Advisorno datano datano data
Dusan Kotasek
Scientific Advisorno datano datano data

4.6yrs

Average Tenure

63yo

Average Age

Experienced Board: X70's board of directors are considered experienced (4.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.